United Scientific Group hosted its first edition of International Conference on Biomarker Research in Clinical Medicine (BRCM 2018) at Paris Marriott Charles de Gaulle Airport Hotel, Paris, France from February 19-21, 2018 and called upon the scientific community to take the biomolecular signature set to a probable next level of therapeutic discovery and application.
The 3-day meeting with the theme – “Uncover different facets of Biomarker study from research to therapy” gathered active researchers focusing on discovery and application of Biomarkers in Clinical Medicine, this proved one of the best opportunity to reach the assemblage of participants, eminent speakers, disseminate information, meet the current and potential speakers/Delegates from all around the world who were working in the very emerging field of Biomarkers. The conference provided a forum for researchers, clinicians and drug designers to present cutting edge research and learn about the latest breakthroughs and technologies in biomarker-related areas.
Biomarker Conference attained greater global significance as it plays a crucial role in the future of biomedical research. Hallmark of the BRCM 2018 conference included keynote speeches from world-renowned speakers – Prof. Harald zur Hausen (Nobel Laureate 2008) & Dr. Wassil Nowicky (President of Ukrainian Anti-Cancer Institute, Austria) and Symposium entitled – Biomarkers as a New Entity through the View of Personalized and Translational Medicine, was held as part of the meeting that had grand expertise of 15 speakers from Russia, France, USA, Germany, Luxembourg, Belgium and New Zealand. The 2-day symposium had keynote speeches from the chairman – Prof. Sergey Suchkov, Director at Center for Personalized Medicine, Sechenov University, Russia; Dr. Irina Zavestovskaya, Director at MEPhI Institute of Engineering Physics for Biomedicine, Russia; Dr. Vladimir Lazar, Founder & COO of WIN Consortium, France & Dr. Catherine Larue, CEO of Integrated BioBank of Luxembourg (IBBL), Luxembourg.
The meeting had excellent talks from some of the distinguished personalities and exchanged knowledge through enlightening talks and networking.
- Prof. Victor Tsetlin, Russian Academy of Sciences (RAS), Russia
- Dr. Christian Garbe, MD of Frankfurt Innovation Center Biotechnology GmbH, Germany
- Prof. David I Smith, Mayo Clinic, USA
- Dr. Claude Prigent, Director of Research at CNRS, France
- Dr. Baolin Zhang, FDA – CDER, USA
- Prof. Christiane Auray-Blais, University of Sherbrooke, Canada
- Prof. Paul Millner, University of Leeds, UK
- Dr. Mu Wang, School of Medicine Indiana University, USA
- Dr. Marc Hendrikx, University of Hasselt, Belgium
- Prof. Hermann Mascher, Founder & bioanalytical consultant at pharm-analyt Labor GmbH, Austria
- Dr. Banu Bayram, Editor-in-Chief of MetaGene, Elsevier
The BRCM 2018 has collaborated with MetaGene, Elsevier and the conference abstracts will be published as Special Issue in the reputed journal. We thank Dr. Banu Bayram, the editor-in-chief of the MetaGene journal for initiating the fruitful collaboration. The meeting also showcased exhibition by M Dialysis, Sweden while pharm-analyt Labor GmbH, Austria was the supporting sponsor.
United Scientific Group and the Biomarkers team thanks all the attendees, presenters and supporters of BRCM 2018 for making the meeting a success. We wish them success for future endeavors. We announce the 2nd edition of Biomarkers Meeting to be held during October 22-24, 2018 in Houston, USA.